Literature DB >> 3922106

Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

H Knecht, E W Schwarze, K Lennert.   

Abstract

172 cases of lymphogranulomatosis X (LgX) were studied by light microscopy. In 53 cases immunohistological techniques for detecting intracytoplasmic immunoglobulins were applied. In the lymph nodes of all cases the nodal architecture was found to be effaced. Active germinal centres were absent, and there was a generalized, markedly increased proliferation of epithelioid venules. A polymorphic infiltrate was present in all cases. It was dominated by immunoblasts in 14%, by plasma cells in 16%, by epithelioid cells in 23% and by lymphocytes in 6% of the cases. In the remaining 41% of the cases no special type of cell predominated (mixed cell type of LgX). The clusters of clear cells present in some cases with immunoblastic predominance did not stain for intracytoplasmic immunoglobulins; in contrast, the basophilic immunoblasts exhibited a polyclonal Ig pattern. In some of the cases with lymphocytic predominance most of the lymphocytes showed abundant cytoplasm with azurophil granules. Transformation into malignant lymphoma was proven at autopsy in 5 of 38 cases (13.2%). Malignant transformation (biopsy and autopsy material) was confirmed in a total of 11 of 172 cases (6.4%) and suspected in an additional 7%. Among the malignant lymphomas were one immunologically proven B-immunoblastic lymphoma, one peripheral T cell lymphoma and 5 cases of Hodgkin's disease. An association between LgX and carcinoma was histologically verified in 7 cases. 26 cases with active germinal centres and 11 cases with only locally pronounced vascularization but with histological and cytological changes that were otherwise similar to LgX were designated as hyperimmune reactions (HR). These cases had a significantly better prognosis. Two cases that presented as HR with active germinal centres later developed into LgX. It is suggested that the disappearance of active germinal centres is important in the pathogenesis of LgX. The possibility that this may correspond morphologically to an alteration of different components of the T-cell system is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922106     DOI: 10.1007/bf00710561

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  64 in total

1.  GERMINAL CENTER CHANGES AND PLASMA CELL REACTION DURING THE PRIMARY IMMUNE RESPONSE.

Authors:  M G HANNA
Journal:  Int Arch Allergy Appl Immunol       Date:  1965

2.  Splenic white pulp alteration after antigen injection: relation to time of serum antibody production.

Authors:  C C CONGDON; T MAKINODAN
Journal:  Am J Pathol       Date:  1961-12       Impact factor: 4.307

3.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

4.  Immunoblastic lymphadenopathy: a prelymphomatous state of immunoblastic sarcoma.

Authors:  R J Lukes; B H Tindle
Journal:  Recent Results Cancer Res       Date:  1978

5.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

6.  Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice.

Authors:  E B Jacobson; L H Caporale; G J Thorbecke
Journal:  Cell Immunol       Date:  1974-09       Impact factor: 4.868

7.  [Clinical course, therapy and malignant transformation of lymphogranulomatosis X (including (angio)immunoblastic lymphadenopathy)].

Authors:  H Knecht; K Lennert
Journal:  Schweiz Med Wochenschr       Date:  1981-07-25

8.  Angioimmunoblastic lymphadenopathy with paraproteinemia: a T- and B-cell disorder.

Authors:  A Klajman; A Yaretzky; M Schneider; Y Holoshitz; A Shneur; B Griffel
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

9.  Monoclonal evolution of angioimmunoblastic lymphadenopathy.

Authors:  L Boros; A G Bhaskar; J P D'Souza
Journal:  Am J Clin Pathol       Date:  1981-06       Impact factor: 2.493

10.  Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.

Authors:  J A Habeshaw; P F Catley; A G Stansfeld; R L Brearley
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more
  6 in total

1.  Atypical immunoproliferative disorders: when of age?

Authors:  G Frizzera
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

2.  Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements.

Authors:  K Willenbrock; A Roers; C Seidl; H H Wacker; R Küppers; M L Hansmann
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

3.  In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study.

Authors:  Klaus Willenbrock; Christoph Renné; Philippe Gaulard; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.064

4.  Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders.

Authors:  H Griesser; A Feller; K Lennert; M Minden; T W Mak
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

Authors:  A Bräuninger; T Spieker; K Willenbrock; P Gaulard; H H Wacker; K Rajewsky; M L Hansmann; R Küppers
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

6.  Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome.

Authors:  A C White; B Z Katz; J A Silbert
Journal:  Yale J Biol Med       Date:  1989 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.